Among them, the combination strategy of anti- Tumor Necrosis Factor Alpha (anti-TNF-α) agents and anti-VEGF drugs has shown a synergistic effect in neovascular glaucoma (Zhou et al., 2023; Carrola et al., 2021). This evidence concerns the gene TNF and neovascular glaucoma.